HEPATITIS B vaccineHEPATITIS B -- VaccinationHAEMOPHILUS influenzaeTreatmentDiscusses research being done on the immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B and conjugated Haemophilus influenzae type b (Hib) vaccines. Reference to a study by G. Gabuti, G. Bona, P. Dentico, ...
内容提示: ADIS DRUG EVALUATIONDTaP-IPV-Hep B-Hib Vaccine (Hexaxim ? )A Review of its Use in Primary and Booster VaccinationPaul L. McCormackPublished online: 22 January 2013? Springer International Publishing Switzerland 2013Abstract Hexaxim ? (DTaP-IPV-Hep B-Hib) is a new,thiomersal-free, ...
liquid, ready-to-use, hexavalent vaccine approved in the EU since 2013 for primary and booster vac- cination in infants and toddlers from age 6 weeks against diphtheria, tetanus, pertussis, hepatitis B (HB), poliomyelitis, and invasive diseases caused by Haemophilus influe...
Hexaxim() (DTaP-IPV-Hep B-Hib) is a new, thiomersal-free, fully liquid, hexavalent combination pediatric vaccine containing diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, recombinant hepatitis B virus surface antigen produced in the yeast Hansenula polymorpha, and Haemophilu...
We assessed the safety and immunogenicity of a fully liquid, DTPw-HepB-Hib combination vaccine (Quinvaxem) in comparison with separately administered DTPw-Hib and hepatitis B vaccines. Infants participating in this open-label, randomized, phase II study received a primary vaccination course using a...
IMMUNOGENICITY AND REACTOGENICITY IN INFANTS IMMUNISED WITH A NEW PENTAVALENT(DTwP-Hib-Hep B) VACCINE. |[utrif]| 1071IMMUNOGENICITY AND REACTOGENICITY IN INFANTS IMMUNISED WITH A NEW PENTAVALENT(DTwP-Hib-Hep B) VACCINE. |[utrif]| 1071Pediatric Research publishes original papers, invited reviews, a...
ScienceDirect® is a registered trademark of Elsevier B.V. Cookies are used by this site. To decline or learn more, visit our Cookies page Switch to Mobile Site Recommended articles No articles found. Citing articles (0) This article has not been cited. Related book content No ...
(DTaP-IPV-Hep B-Hib) is a new,thiomersal-free, fully liquid, hexavalent combination pediatricvaccine containing diphtheria and tetanus toxoids, acellularpertussis, inactivated poliovirus, recombinant hepatitis B virussurface antigen produced in the yeast Hansenula polymorpha,and Haemophilus inf l uenzae ...
A compact pre-filled auto-disable injection (cPAD) presentation is being developed for the fully liquid pentavalent DTP-HepB-Hib vaccine. A cost analysis (CA) to compare this presentation with the presently used single-dose vial (SDV) and multi-dose vial (MDV) was conducted in Cambodia, Ghan...
Haemophilus influenzae type BPRPHexavalentBackground DTaP-IPV-Hib-HepB is a fully-liquid, hexavalent combination vaccine (Vaxelis) approved for vaccination against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib). Hib capsular...